Prevalence of Sleep-Related Disordered Breathing among Acromegaly Patients and its Correlation to Cephalometric Parameters: An Indian Perspective

Abstract

Introduction Sleep-related breathing disorders (SRBDs) including obstructive sleep apnea (OSA) and central sleep apnea (CSA) are quite common and are the leading causes of mortality in acromegaly. OSA in acromegaly is generally attributed to changes in oropharyngeal soft tissues. Data on OSA in Indian acromegaly are scant, especially cephalometric findings. The aim of this study is to evaluate the burden of SRBDs in acromegaly and its correlation to cephalometric parameters.

Materials and Methods A total of 32 subjects (20 men and 12 women), diagnosed with acromegaly on the basis of standard clinical, biochemical, and hormonal measurements were recruited. In addition to the above parameters, polysomnography and magnetic resonance imaging (MRI) of the pharynx were performed in all subjects.

Results The mean age of the subjects was 42.66 ± 11.13 years (range = 26–66) and mean duration of study after first presentation was 7.6 ± 6.3 years (range = 0.25–32). A total of 28 of 32 (93.3%) subjects had sellar MRI documented macroadenomas while 20 (62.5%) patients were treatment naive at the time of assessment. Twenty-nine (90.6%) patients had evidence of SRBD and all of them had OSA subtype. The Apnea–Hypopnea Index (AHI) indicating severity of OSA (mild 21.8%, moderate 34.4%, and severe 34.4%) correlated positively with tongue length, uvula length, and uvula thickness on MRI. However, AHI had no correlation with the severity of GH excess or disease activity or individual parameters such as weight, body mass index, blood pressure, hemoglobin A1c, serum human growth hormone, and insulin-like growth factor-1 level.

Conclusion SRBD, the generally overlooked comorbidity, is highly prevalent in subjects with acromegaly and is almost always due to OSA, the severity of which correlates positively with tongue and uvula size. Well-designed, long-term follow-up study on a large cohort of acromegalic patients is required to improve our understanding on the subject.

Keywords

sleep-related breathing disorder - cephalometry - acromegaly - obstructive sleep apnea - central sleep apnea - Apnea–Hypopnea Index

Publication History

Article published online:
20 April 2020

• References

• 1 Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 2010; 72 (03) 377-382
• 2 Sharma AN, Tan M, Amsterdam EA, Singh GD. Acromegalic cardiomyopathy: epidemiology, diagnosis, and management. Clin Cardiol 2018; 41 (03) 419-425
• 3 van Haute FR, Taboada GF, Corrêa LL. et al. Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging. Eur J Endocrinol 2008; 158 (04) 459-465
• 4 Tsoy UA, Sviryaev YV, Korostovtseva LS. et al. [Clinical features of obstructive sleep apnea syndrome in patients with acromegaly]. Ter Arkh 2015; 87 (04) 47-52
• 5 Vannucci L, Luciani P, Gagliardi E. et al. Assessment of sleep apnea syndrome in treated acromegalic patients and correlation of its severity with clinical and laboratory parameters. J Endocrinol Invest 2013; 36 (04) 237-242
• 6 Hernández-Gordillo D, Ortega-Gómez MdelR, Galicia-Polo L. et al. Sleep apnea in patients with acromegaly. Frequency, characterization and positive pressure titration. Open Respir Med J 2012; 6: 28-33
• 7 Vouzouneraki K, Franklin KA, Forsgren M. et al. Temporal relationship of sleep apnea and acromegaly: a nationwide study. Endocrine 2018; 62 (02) 456-463
• 8 Parolin M, Dassie F, Alessio L. et al. Obstructive sleep apnea in acromegaly and the effect of treatment: a systematic review and meta-analysis. J Clin Endocrinol Metab 2020; 105 (03) dgz116
• 9 Attal P, Chanson P. Screening of acromegaly in adults with obstructive sleep apnea: is it worthwhile. ? Endocrine 2018; 61 (01) 4-6
• 10 Dostálová S, Sonka K, Smahel Z, Weiss V, Marek J. Cephalometric assessment of cranial abnormalities in patients with acromegaly. J Craniomaxillofac Surg 2003; 31 (02) 80-87
• 11 Guo X, Gao L, Zhao Y. et al. Characteristics of the upper respiratory tract in patients with acromegaly and correlations with obstructive sleep apnoea/hypopnea syndrome. Sleep Med 2018; 48: 27-34
• 12 Gadelha MR, Kasuki L, Lim DST, Fleseriu M. Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev 2019; 40 (01) 268-332
• 13 Dutta P, Hajela A, Pathak A. et al. Clinical profile and outcome of patients with acromegaly according to the 2014 consensus guidelines: impact of a multi-disciplinary team. Neurol India 2015; 63 (03) 360-368
• 14 Lohman T, Roche F, Mantorell R. Anthropometric standardized reference manual. Abridged Edition Page 1992; 42: 44
• 15 Kapur VK, Auckley DH, Chowdhuri S. et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2017; 13 (03) 479-504
• 16 Castellani C, Francia G, Dalle Carbonare L. et al. Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients. Endocrine 2016; 51 (02) 308-316
• 17 Sesmilo G, Resmini E, Sambo M. et al. ACROSAHS study group. Prevalence of acromegaly in patients with symptoms of sleep apnea. PLoS One 2017; 12 (09) e0183539
• 18 Ip MS, Tan KC, Peh WC, Lam KS. Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clin Endocrinol (Oxf) 2001; 55 (04) 477-483